Vincent Gies Yannick Dieudonné Florence Morel Wladimir Sougakoff Raphaël Carapito Aurélie Martin Noëlle Weingertner Léa Jacquel Fabrice Hubele Cornelia Kuhnert Sophie Jung Frederic Schramm Pierre Boyer Yves Hansmann François Danion Anne-Sophie Korganow Aurélien Guffroy
10.3389/fimmu.2021.696268
Front Immunol
2021 Aug 3;12:696268.
bcg bcgosis-susceptible pids immunodeficiency case report contamination hematological malignancies
CC BY
https://pubmed.ncbi.nlm.nih.gov/34413849/
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Hematologic Neoplasms / drug therapy Immune Reconstitution Immunocompromised Host Mycobacterium bovis / pathogenicity Opportunistic Infections / microbiology Tuberculosis, Pulmonary / microbiology
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Hematologic Neoplasms / drug therapy Immune Reconstitution Immunocompromised Host Mycobacterium bovis / pathogenicity Opportunistic Infections / microbiology Tuberculosis, Pulmonary / microbiology Case Reports Research Support, Non-U.S. Gov't Administration, Intravesical Antineoplastic Combined Chemotherapy Protocols / adverse effects Antitubercular Agents / therapeutic use BCG Vaccine / administration & dosage BCG Vaccine / adverse effects Host-Pathogen Interactions Humans Male Middle Aged Mycobacterium bovis / drug effects Mycobacterium bovis / immunology Opportunistic Infections / drug therapy Opportunistic Infections / immunology Risk Factors Treatment Outcome Tuberculosis, Pulmonary / diagnosis Tuberculosis, Pulmonary / drug therapy Tuberculosis, Pulmonary / immunology Urinary Bladder Neoplasms / drug therapy Urinary Bladder Neoplasms / immunology Antitubercular Agents BCG Vaccine
PMC8369751
34413849
Case Report: Acquired Disseminated BCG in the Context of a Delayed Immune Reconstitution After Hematological Malignancy
2021